Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Daisy Bray
Regulation of Laboratory Developed Tests in APAC | JD Supra
Laboratory Developed Tests (LDTs) are critical for diagnosing rare diseases and addressing unmet clinical needs. They are developed, manufactured, and used within a single licensed clinical laboratory for purposes of clinical diagnosis, and generally developed in response to emerging health needs. Yet there is no standard definition of an LDT across APAC markets.
Addressing Supply Chain Vulnerabilities and Supply Shortages of Critical Essential Medicines: The Latest EU Legislative Proposal for a Critical Medicines Act
Challenges to global supply chain integrity for critical essential medicines The COVID-19 pandemic has heightened the focus on effectively managing supply disruptions of life-saving, high-quality medicines. Additionally, ongoing geopolitical instability has begun to threaten global supply chains of essential medications.
MHRA Launches The 2025 Pilot Real-World Evidence Dialogue Programme - Implementing Broader Data Strategy And Pro-Innovation Regulatory Framework
RG Ropes & Gray LLP More Ropes & Gray is a preeminent global law firm with approximately 1,400 lawyers and legal professionals serving clients in major centers of business, finance, technology and government. The firm has offices in New York, Washington, D.C., Boston, Chicago, San Francisco, Silicon Valley, London, Hong Kong, Shanghai, Tokyo and Seoul. The MHRA launched its 2025 Real-World Evidence (RWE) Scientific Dialogue Programme to enhance regulatory and HTA evaluations.
New 2021 Code Of Practice For The British Pharmaceutical Industry
United States: New 2021 Code Of Practice For The British Pharmaceutical Industry 27 January 2021 by Adela Williams , Louise Strom and Daisy Bray Arnold & Porter Your LinkedIn Connections with the authors To print this article, all you need is to be registered or login on Mondaq.com.
New 2021 Code of Practice for the British Pharmaceutical Industry
The UK’s Association of the British Pharmaceutical Industry (ABPI) has, together with the Prescription Medicines Code of Practice Authority (PMCPA), published the new Code of Practice for the Pharmaceutical Industry (the 2021 Code). Publication of the 2021 Code follows a consultation conducted in 2020, with subsequent revisions prior to approval on 12 January 2021. The 2021 Code will be implemented from 1 July 2021 and represents a significant structural revision of the current 2019 Code.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Daisy
Contact Daisy, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack